Search

everythinglearnresearchcommunity

for

Search:↓

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

The author now believes tricholemmal carcinoma is a rare type of infundibular squamous cell carcinoma and more research is needed on these tumors.

The conclusion is that Pigmented Epithelioid Melanocytoma can start from hair follicle stem cells or from a mole on the skin.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

LSD1 is essential for healthy skin development and creating the skin's protective barrier.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

The skin lesion was diagnosed as a matrical cyst with unusual features.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Oncogenic K-ras causes rapid cancerous changes in the mouth's lining.

The Walleye dermal sarcoma virus cyclin causes excessive skin cell growth in mice.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Loss of Dnmt3a and Dnmt3b increases aggressive skin tumors by affecting PPAR-γ.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

AP-1 controls tumor cell type by affecting key signaling pathways.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

Most U.S. keratinocyte carcinoma patients are older white males living in urban areas.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

The method effectively induces skin cancer in mice for studying tumor development.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Keratin 15 cells from hair follicles help develop and maintain skin tumors in mice.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.